Dr. John Cole, MD
Claim this profileOchsner Medical Center Jefferson
Area of expertise
Breast Cancer
John Cole, MD has run 8 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
John Cole, MD has run 7 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Ochsner Medical Center Jefferson
Ochsner Medical Center Kenner
Clinical Trials John Cole, MD is currently running
Internet-Based Pain Management Program
for Cancer Survivors
To determine whether an Internet-based pain coping skills program plus enhanced usual care, compared to enhanced usual care alone, yields significant improvements in the co-primary outcomes of pain severity (as measured by the Brief Pain Inventory (BPI)) and pain interference (also measured by the BPI) from baseline to the post-intervention assessment for cancer survivors with persistent pain.
Recruiting
1 award
N/A
17 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting
1 award
Phase 2
17 criteria
More about John Cole, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments John Cole, MD has experience with
- Paclitaxel
- Cyclophosphamide
- Carboplatin
- Biospecimen Collection
- Nilotinib Hydrochloride Monohydrate
- Pelareorep
Breakdown of trials John Cole, MD has run
Breast Cancer
Breast cancer
Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Cole, MD specialize in?
John Cole, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage III.
Is John Cole, MD currently recruiting for clinical trials?
Yes, John Cole, MD is currently recruiting for 3 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that John Cole, MD has studied deeply?
Yes, John Cole, MD has studied treatments such as Paclitaxel, Cyclophosphamide, Carboplatin.
What is the best way to schedule an appointment with John Cole, MD?
Apply for one of the trials that John Cole, MD is conducting.
What is the office address of John Cole, MD?
The office of John Cole, MD is located at: Ochsner Medical Center Jefferson, New Orleans, Louisiana 70121 United States. This is the address for their practice at the Ochsner Medical Center Jefferson.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.